The role of FLT3 in haematopoietic malignancies

By D. Stirewalt, J. Radich. Nature Reviews. Cancer, 2003

920 citations recorded by the source corpus.

Subfields: Genetics, Hematology

View Paper: https://www.semanticscholar.org/paper/a122693b1bc736f02fa2ad90d34024145b76896c

Citations in the corpus

• The origin and evolution of mutations in Acute Myeloid Leukemia (2012, neutral): “Targeted sequencing efforts have identified several mutations that carry diagnostic and prognostic information, including mutations in FLT3, NPM1, KIT, CEBPA, and TET2 (reviewed in (Bacher et al., 2010; Stirewalt and Radich, 2003)).”
• The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. (2008, neutral): “M7 21 20 (95) 1 (5) 0 0 — 16 12 (75) 4 (25) —”
• Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). (2006, neutral): “Median platelet count, 109/L (range) 68 (7-302)* 56 (3-514) 47 (5-372) 46 (4-1430)”